The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 35, Issue 2, 2000, Pages 398-404

  Swedberg, Karl ^a   Bergh, Claes Håkan ^a   Dickstein, Kenneth ^b   McNay, John ^a,b,c   Steinberg, Mitchell ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLINE DERIVATIVE; MOXONIDINE; NORADRENALIN;

ADRENERGIC STIMULATION; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NOREPINEPHRINE; PLATELET AGGREGATION INHIBITORS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 0034005502     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00565-3     Document Type: Article

References (35)